Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic | Zendy

Elizabeth B. Lamont | Zendy; Sheila Diamond | Zendy; Ron G. Katriel | Zendy; Lisa Ensign | Zendy; Jingshu Liu | Zendy; Emelly Rusli | Zendy; G. Caleb Alexander | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic

Author(s) -

Elizabeth B. Lamont,

Sheila Diamond,

Ron G. Katriel,

Lisa Ensign,

Jingshu Liu,

Emelly Rusli,

G. Caleb Alexander

Publication year - 2021

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.36353

Subject(s) - pandemic , covid-19 , clinical trial , medicine , oncology , disease , virology , infectious disease (medical specialty) , outbreak

The coronavirus disease 2019 (COVID-19) pandemic due to the novel severe acute respiratory syndrome coronavirus 2 has resulted in significant morbidity and mortality since its genesis in China in late 2019, with an estimated 1 602 500 deaths and 71 541 897 infections throughout the world as of December 12, 2020.1 The pandemic’s direct impact on population health and associated collateral morbidity and mortality resulting from delays in care for disparate conditions have been described elsewhere.2-6 We evaluated the association between the pandemic and clinical research and development for an as yet non-COVID-19–associated condition, cancer, by studying the initiation of oncology clinical trials over time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research